Ergoteles LLC Biogen Inc. Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$256.56 - $292.34 $2.59 Million - $2.95 Million	-10,087 Reduced 86.07%	1,632 $453,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $2.96 Million - $3.59 Million	11,719 New	11,719 $3.25 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $11.1 Million - $14.5 Million	-39,277 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$259.0 - $414.71 $10.2 Million - $16.3 Million	39,277 New	39,277 $13.6 Million
Q1 2021 May 12, 2021	SELL	$242.95 - $284.63 $12.7 Million - $14.9 Million	-52,452 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$236.26 - $355.63 $5.49 Million - $8.27 Million	23,252 Added 79.63%	52,452 $12.8 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $7.73 Million - $8.93 Million	29,200 New	29,200 $8.28 Million

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.